Skip to content
MedsAcross

Molecule

Cefixime

Cephalosporin Antibacterial
Available on requestAntibiotics
Presentations
4
Brands
0
Manufacturers
0
Available from stock
0

Cefixime is a cephalosporin antibacterial indicated in the treatment of adults and pediatric patients six months and older with infections, among other approved uses. It is available as capsules, powder for oral suspension and tablets. MedsAcross supplies Cefixime for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Key facts

Pharmacological class
Cephalosporin Antibacterial
ATC classification
J01DD08 Cefixime · Cephalosporin antibiotic
US FDA first approval
28 April 1989
EU status
Not recorded
Orphan designation
Not recorded
WHO essential medicine
Not recorded
India (CDSCO)
Not yet confirmed against CDSCO approval lists
Routes
Oral
Dosage forms
Capsule, Powder for oral suspension, Tablet
Identifiers
UNII XZ7BG04GJXRxCUI 1546021CAS 79350-37-1DrugBank DB00671Q163901

Clinical information

From the regulator-approved product information. Each section names its source.

Uses

Cefixime is a cephalosporin antibacterial drug indicated in the treatment of adults and pediatric patients six months and older with the following infections: Uncomplicated Urinary Tract Infections. Otitis Media. Pharyngitis and Tonsillitis. Acute Exacerbations of Chronic Bronchitis. Uncomplicated Gonorrhea (cervical/urethral). Usage to Reduce Development of Drug-Resistant Bacteria To reduce the development of drug-resistant bacteria and maintain the effectiveness of cefixime and other antibacterial drugs, cefixime for oral suspension and cefixime capsules should be used only to treat infections that are proven or strongly suspected to be caused by bacteria.

Source: US FDA prescribing information

Dosing overview

Adults: 400 mg daily. Pediatric patients (6 months and older): 8 mg/kg/day Adults The recommended dose of cefixime is 400 mg daily. This may be given as a 400 mg capsule daily. For the treatment of uncomplicated cervical/urethral gonococcal infections, a single oral dose of 400 mg is recommended. The capsule may be administered without regard to food. In the treatment of infections due to Streptococcus pyogenes, a therapeutic dosage of cefixime should be administered for at least 10 days.

Source: US FDA prescribing information

Contraindications

Contraindicated in patients with known allergy to cefixime or other cephalosporins. Cefixime is contraindicated in patients with known allergy to cefixime or other cephalosporins.

Source: US FDA prescribing information

Warnings and precautions

Hypersensitivity reactions including shock and fatalities have been reported with cefixime. Discontinue use if a reaction occurs. Clostridiodes difficile- Associated Diarrhea: Evaluate if diarrhea occurs.

Source: US FDA prescribing information

Side effects

Most common adverse reactions are gastrointestinal such as diarrhea (16%), nausea (7%), loose stools (6%), abdominal pain (3%), dyspepsia (3%), and vomiting.

Source: US FDA prescribing information

Interactions

Elevated carbamazepine levels have been reported in postmarketing experience when cefixime is administered concomitantly. Increased prothrombin time, with or without clinical bleeding, has been reported when cefixime is administered concomitantly with warfarin and anticoagulants.

Source: US FDA prescribing information

Storage

Store drug powder at 20°C to 25°C (68°F to 77°F). Cefixime capsules, 400 mg is size "0" capsule with pink opaque cap and pink opaque body, imprinted with "LU" on cap and "U43" on body in black ink, containing white to yellowish white granular powder containing 400 mg of cefixime as the trihydrate and is supplied as follows: NDC 68180-423-08 - Bottle of 50 capsules NDC 68180-423-11 - Unit dose Package of 10 (1 blister of 10 capsules) Store at 20 °C to 25°C (68°F to 77°F). After reconstitution: Store at room temperature or under refrigeration.

Source: US FDA prescribing information

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

All presentations

4 presentations of Cefixime, sorted by availability.

MedicineManufacturerRegisterAvailability
Cefixime 400 mg capsuleOralGeneric name—US FDAAvailable on request
Cefixime 200 mg/5 mL powder for oral suspensionOralGeneric name—US FDAAvailable on request
Cefixime 100 mg/5 mL powder for oral suspensionOralGeneric name—US FDAAvailable on request
Cefixime 400 mg tabletOralGeneric name—US FDAAvailable on request

Regulatory status

Approval facts from US FDA, EMA and CDSCO data, and registration status by country where we hold register data.

RegisterStatusSource
US FDAFirst approved 28 April 1989Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Conditions

Conditions linked to Cefixime in public data. This is not a list of approved uses, see the clinical information.

Acute bronchitis Bacterial pneumonia Bronchitis Erysipelas Escherichia coli infectious disease Gonorrhea Gram-negative bacterial infection Otitis media Paratyphoid fever Staphylococcal infection Streptococcal pharyngitis Typhoid fever Upper respiratory tract infection Urinary tract infection

Questions and answers

Is Cefixime available for export from India?

Yes, on request. MedsAcross lists 4 presentations of Cefixime and sources them for licensed hospitals, importers and physicians against valid import documents.

Is Cefixime approved by the US FDA?

Yes. The US FDA first approved Cefixime on 28 April 1989, according to Drugs@FDA.

Does Cefixime need cold chain shipping?

No listed presentation of Cefixime is recorded as needing a cold chain. Storage conditions are shown on each presentation page.

Which ATC class is Cefixime in?

Cefixime is classified under ATC code J01DD08 (Cefixime).

References

  1. CEFIXIME prescribing information (Lupin). U.S. National Library of Medicine, DailyMed. Retrieved 14 October 2025

Request Cefixime for export supply

Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.

Request a quoteRead the import guides